Related Experiment Video
Updated: May 25, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion tensor imaging analysis of tumefactive giant brain lesions in multiple sclerosis
Shmuel Miron1, Sigal Tal, Anat Achiron
1Multiple Sclerosis Center, Sheba Medical Center, Ramat-Gan, Israel. Shmuel.Miron@sheba.health.gov.il
Summary
Tumefactive giant brain lesions (TGL) in multiple sclerosis (MS) show high diffusivity and low directionality, indicating intense inflammation. Diffusion tensor imaging (DTI) can track these micro-structural changes during lesion recovery.
Area of Science:
- Neuroimaging
- Radiology
- Neurology
Background:
- Diffusion tensor imaging (DTI) measures water diffusion in brain tissue.
- Inflammation disrupts tissue, increasing diffusivity and decreasing directionality.
- Tumefactive giant brain lesions (TGL) are a rare manifestation of multiple sclerosis (MS).
Purpose of the Study:
- To quantify tissue damage in MS-related TGL using MRI and DTI.
- To compare DTI metrics of TGL with acute MS lesions.
- To assess micro-structural changes in TGL over time.
Main Methods:
- Regions of interest were defined on TGL and acute MS lesions.
- Key DTI metrics analyzed included volume, apparent diffusion coefficient (ADC), fractional anisotropy (FA), axial diffusivity (λ||), and radial diffusivity (λ⊥).
Main Results:
- TGL exhibited significantly higher ADC, λ||, and λ⊥, and lower FA compared to acute MS lesions (P <.001).
- Follow-up MRI/DTI after 120 days showed decreased TGL volume, reduced ADC, λ||, and λ⊥, and increased FA (P < .01).
Conclusions:
- TGL display DTI characteristics indicative of intense acute inflammation within the MS lesion spectrum.
- DTI metrics are sensitive to micro-structural changes in TGL, reflecting progression from acute inflammation to recovery and reorganization.
Related Concept Videos
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

